From the methanolic extract of fresh fruits of Solanum reflexum Schrank, a major compound was isolated and identified as; aculeatiside-A 1. The structure of the isolated compound was elucidated on the basis of 1 H and 13 C and DEPT-13 C-NMR; in addition to comparison with reported data. The cytotoxic effect of aculeatiside-A on hepatocellular carcinoma cells and its mechanism was investigated. It was accomplished that aculeatiside-A inhibit the growth of HepG-2 cells significantly by induction of apoptosis. Marked morphological changes of apoptosis were observed clearly. The results for the first time demonstrate that aculeatiside-A has significant anti-proliferation effect by induction of apoptosis on hepatocellular carcinoma cells in-vitro, down regulation of Survivin and Bcl-2 expressions as well as up regulation of Bax and P 53 expression may be one of the important apoptotic inducing mechanisms.
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INTRODUCTION
Plants are inexhaustible sources of complex chemical molecules produced as a result of their secondary metabolism. Mainly, alkaloids and saponins have attracted special interest owing to its vital and therapeutic effect on the human body. Solanum is the largest genus in Solanaceae family with about 1700-2000 species distributed throughout the temperate and tropical regions of the world 1 . Solanum reflexum Schrank has been used to treat toothache, skin complaints, bronchitis and rheumatism in China and solasodine, solasonine and solamargine are known as constituents of this plant 2 . In our studies on the oriental Solanum plants, we have now isolated compound 1 3&4 , which is a steroidal glycoside, named aculeatiside-A for the first time from the fruits of Solanum reflexum Schrank, and elucidated its structure. No records were observed regarding the cytotoxicity bioassay of aculeatiside-A upon tracing its biological activities, which encouraged us to investigate its cytotoxic action.
Despite recent advance in understanding the molecular biology of hepatocellular carcinoma cells and the induction of some new chemotherapeutic agents for the treatment of this malignant disease, there are few efficient therapeutic measures or regimes especially for the patients who are in the mid or final stages, and the dismal 5-year survival rate has not changed too much for this leading cause of cancer deaths in the world 5&6 . Therefore, it is a permanent subject to find new drugs and effective therapies for the clinical treatment of hepatocellular carcinoma. It is recently reported that plant-derived compounds are known to have curative potential.
The present study was undertaken to investigate the cytotoxic effect of aculeatiside-A on hepatocellular carcinoma cells and its possible mechanism. Hepatocellular carcinoma cell line, HepG-2 cells, was used. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (MTT). Cell morphology was observed by the phase contrast microscope under normal or trypan blue stain. Reverse transcriptase-polymerase chain reaction was used to estimate expression of Survivin and P 53 mRNAs while Western blot analysis was used to detect Bax and Bcl-2 expressions.
EXPERIMENTAL
NMR spectra ( 1 H, 13 C, DEPT-13 C-NMR) were measured in pyridine-d 5 on a JEOL α-500 spectrometer (Japan). Column chromatography was carried out on silica gel 60 (70-230, 230-400 mesh, Merck). TLC was carried on precoated silica gel plates G60 F 254 (0.2 mm Aluminium sheets, Merck) and RP-18 F 254S (0.2 mm Aluminium sheets, Merck). Plates were visualized by spraying with 20% v/v H 2 SO 4 in EtOH, allowed to dry at room temperature and heated at 110-140°C for 1-2 min. All solvents were double distilled prior using. All chemicals are of analytical grade. Authentic sugar samples were obtained from Sigma-Aldrich Company (Germany). The fresh fruits of Solanum refelxum (2 Kg) was cut into small pieces and extracted three times with hot methanol (5 L. each time).
The methanolic extracts were combined and then concentrated under reduced pressure to give 30 g of yellowish brown residue, labeled SRF, which showed the presence of one major spot, in addition to five minors on TLC. 
Glc
Cell culture HepG-2 cells were purchased from Serum and Vaccine Research Institute, Cairo, Egypt. Cells were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum (FBS), containing 100 U/ml penicillin and l00 µg/ml streptomycin, in a humidified incubator with 5% CO 2 at 37°C. Cells were passed twice weekly and routine examination was also done for mycoplasma contamination. Cells in logarithmic growth phase were used for the experiments 7 .
Cell viability assay
The viability of the cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, which is based on the reduction of MTT by the mitochondrial dehydrogenase of intact cells to a purple formazan product. Briefly, HepG-2 cells in logarithmic growth phase were collected, and 5000 cells/well were dispensed within 96-well culture plates in 100µl volumes. Then different concentrations of aculeatiside-A (25, 50, 100 and 200 µg/ml final concentration) were added in different wells. We added 1% DMSO, solvent of the aculeatiside-A, to the control wells. Every concentration or the control was contained in three parallel wells. Culture plates containing the aculeatiside-A were then incubated for 24, 48 and 72 hrs prior to the addition of tetrazolium reagent. MTT working solution, 5 mg MTT/ml PBS, was sterilized by filtration using 0.45 µm filters. Each well received 20 µL of MTT working solution and incubated for further 5 hrs. The culture medium was removed carefully without disturbing the formazan layer. The water insoluble formazan was dissolved by addition of 100 µl DMSO to each well. Amount of formazan was determined by measuring the absorbance at 600 nm using, metertech Σ960, ELISA reader 8 .
Detection of mRNA expressions using RT-PCR
The expressions of survivin and P 53 in HepG-2 cells were examined by RT-PCR before and after the cells were treated with different concentrations of aculeatiside-A for 24, 48 and 72 hrs. The total RNA was extracted by using total RNA extraction kit from (BioFlux, Bioer Technology Co., Ltd.) according to the instruction manual. The first strand cDNA was synthesized according to the instruction manual of RevertAid TM First strand cDNA synthesis kit (Fermentas). The PCR performed using Tag master/high yield (Jena Bioscience) as following condition; predenaturing for 5 min at 94°C then denaturing at 94°C for 30 sec, annealing 55°C, and extension at 72°C for one min. The amplification was carried out in 28 cycle using (Biometra cycler). The PCR products were then run on 1.5% agarose gel in TAE buffer for 40 min, at 75V and then visualized by ethidium bomide staining.
Western blot analysis
For Western blotting, cells were washed with ice-cold PBS twice and lysed for 30 min at 4°C in NED buffer, then debris was removed by centrifugation for 15 min at 14,000 rpm at 4°C. 50 µg from each concentration were denatured by boiling for 5 min in 2% SDS and 5% 2-mercaptoethanol and loaded in each lane. SDS-PAGE was done at 100 volts for 2 hrs using 12% gel. The electrotransfer was done using T-77 ECL semi-dry transfer unit (Amersham Biosciences) for 2 hrs. The membranes were blocked in TBS buffer that contains 0.05 Tween and 5% non-fat milk for one hour. The membranes were reacted firstly with rabbit polyclonal antibodies; anti-Bcl-2 and anti-Bax at a dilution of 1:300 for 2 hrs, followed by extensive washes with PBS twice and TBST twice. Membranes then incubated with the secondary antibody, polyclonal goat anti-rabbit immunoglobulin conjugated to alkaline phosphatase (Sigma-Aldrich, Schelldorf, Germany), diluted 1:5000 9 .
Oligonucleotides used for amplifications NCBI reference sequence: NM_000546.4, NM_001168.2 and NM_002046.3 were used for design primers for P 53 , survivin and GAPDH respectively. The coding sequences were used to design the primer pairs as shown in table 2.
Statistical analysis
All experiments were performed in triplicates and the results were expressed as mean ± SD. Statistical analysis was performed with t-test using SPSS-10 software. Anti-sense primer: 5-GTCATGAGTCCTTCCACGA-3
RESULTS AND DISCUSSION
The 1 H-NMR spectra of compound 1 exhibited a set of signals due to three tertiary methyl groups at δ H 0.83, 1.04 and 1.39 each (3H, s) and three secondary methyl signals at δ H 1.09 (3H, d, J= 6.71 Hz), 1.62 (3H, d, J= 5.5
Hz) and 1.75 (3H, d, J= 6.11 Hz), in addition to four anomeric protons at δ H 4.94 (1H, d, J= 7.33 Hz), 5.3 (1H, partially obscured by C 5 D 5 N signal), 5.81(1H, s) and 6.34 (1H, s) 3&4 . The afore mentioned data in combination with 13 C-NMR illustrated on table 1 suggested that compound 1 is a nautigenin tetraglycoside ( Fig.  1) ; in which, its sugar component consists of one mole of glucose linked to C-26 together with an additional glucose unit and two moles of rhamnose linked to C-3 of the aglycone part 3&4 . The 13 C-NMR revealed the presence of three anomeric carbons at δ C 100.29, 102.02 and 102.91, among which two anomeric carbon signals at δ C 102.02 and 102.91 were ascribable to two terminal rhamnosyl moieties attached to C-2 and C-4 of an inner glucosyl molecule with anomeric carbon appeared at δ C 100.29 and this was obvious from the down field shift of C-2 and C-4 from δ C 75.3 and 71.6 to δ C 78.15 and 77.93 respectively 3&4 . These data were assigned to β-chacotriosyl moiety attached to C-3 of the aglycone part. More over an extra glucose unit with anomeric carbon appeared at δ C 105.39, could be attached to the C-26 of the aglycone moiety 3 . From the above mentioned data and by comparison with literature 9&10 ; it was concluded that compound 1 deduced as: 3-O-[α-L-rhamnopyranosyl-(1→2)-α-L-rhamnopyranosyl(1→4)-β-D-glucopyranosyl]nautagenin-26-O-β-D-glucopyranoside, which is also known as aculeatiside-A 9&10 . This is the first reported occurrence of compound 1 in Solanum reflexum Schrank fruits.
Cell viability
To investigate the growth inhibition effect of aculeatiside-A on HepG-2 cells, we treated the cells with different concentrations of aculeatiside-A for 24, 48 and 72 hrs and measured the viability using MTT assay method. As shown in figure 2, aculeatiside-A had significant growth inhibition effect in a time and dose dependant manner. The percent of inhibition of cell proliferation (% IC) To investigate the synergistic affect of curcumin, a known compound that inhibits growth of HepG-2 cells was chosen. We treated the cells with 10 µg/ml curcumin in addition to the aculeatiside-A for 24 hrs. Addition of curcumin causes inhibition of cells growth by 2.34, 1.84, 1.83 and 1.29 folds in comparison to that of aculeatiside-A alone as shown in figure 3 .
Detection of cell apoptosis
To show whether the growth inhibition induced by aculeatiside-A in HepG-2 cells were caused by induction of apoptosis, cells were stained by trypan blue as shown in figure  4 . The living cells attached to the matrix and spindle in shape but after the aculeatiside-A treatment, the cells detached and become spherical in shape. After treatment by 100 µg/ml aculeatiside-A for 72 hrs, the cells were collected and treated with 1% trypan blue. Most of cells showed the criteria of apoptosis that are condensation, small size and stained with deep blue color. The living cells are large and shining.
Expression of apoptosis related genes
After treatment with 100 µg/ml aculeatiside-A for 24, 48, and 72 hrs, RT-PCR analyses was used to detect the variation of apoptosis related genes. The results of RT-PCR demonstrate that the mRNA expression of P 53 , apopototic gene, was up-regulated while the survivin, anti-apoptotic gene was down regulated (as shown in figure 5 ).
Expression of apoptosis related proteins
The cell were collected after treatment with 100µg/ml aculeatiside-A for 24, 48, and 72 hrs, washed and homogenized. Western blot analysis revealed over expression of Bax protein and it was time dependant, concomitantly with decrease in the expression of Bcl-2 protein.
In this study, we found that aculeatiside-A, could inhibit the proliferation by inducing apoptosis on hepatocellular carcinoma cells remarkably when the cells treated with Expression. Cells were treated with 100 µg/ml aculeatiside-A for 24, 48 and 72 hrs then harvested and washed. The total RNA was extracted and cDNA was synthesized from total RNA (2 µg) which was amplified using the sets of primers for examining the expression of P 53 and Survivin. β-actin was used as internal control gene. different concentrations of aculeatiside-A for different times. To clarify the mechanisms of apoptosis caused by aculeatiside-A, we detected the expressions of P 53 and surviving mRNA and protein levels of Bcl-2 and Bax after the cells were treated with 100µg/ml aculeatiside-A for 24, 48 and 72 hrs. RT-PCR and Western blot analysis revealed that both Survivin and Bcl-2 expressions were downregulated remarkably while Bax and P 53 expression up-regulated. Impaired apoptosis is now recognized to be a key step in tumourigenesis 11 . Recently, inducers of apoptosis have been used in cancer therapy and activation of apoptosis pathways is a key mechanism by which cytotoxic drugs kill tumor cells 12 . All these studies indicate that induction of apoptosis is now considered as an important method of assessment for the clinical effectiveness of many anti-tumor drugs 13 .
Survivin, a member of apoptosis inhibitor family, is expressed in most human malignancies and implicated in mitosis regulation and preservation of cell viability 14 .
Previous data have revealed that Survivin is over expressed in tumor cells which play important roles in both cell proliferation and cell death 15 . Recent studies 16&17 have shown that Survivin is over expressed and is almost always present in hepatocellular carcinoma.
Bcl-2 represents the finding member of the new and growing class of cell death inhibiting oncoproteins 18 . The first proapoptotic homologue of Bcl-2 family, Bax, was identified by co-immunoprecipitation with Bcl-2 protein, and the ratio of Bcl-2 to Bax is important in determining susceptibility to apoptosis 19&20 . In this study, our results revealed that Bcl-2 expression was downregulated remarkably in aculeatiside-A induced apoptosis on hepatocellular carcinoma cells.
Survivin and Bcl-2 function through different pathways in the regulation of cell apoptosis. Bcl-2 regulates apoptosis mainly by preventing cytochrome-C release from mitochondrion to cytoplasm 18&20 . Whereas, Survivin directly inhibits the activities of Caspase-3 and 7, and block the process of apoptosis 21 . Previous studies demonstrated that the expression of Survivin was significantly associated with Bcl-2 expression and the expression of Survivin, in conjunction with Bcl-2, might cause more pronounced antiapoptotic effects 22&23 . Therefore the expression of Survivin in cooperation with Bcl-2 is a significant prognostic parameter 24 and a new therapeutic target in cancer 23 .
In the present study, we found that the expressions of both Survivin and Bcl-2 were down-regulated concurrently in aculeatiside-A induced apoptosis on the hepatocellular carcinoma cell lines. Our results agree with the findings of previous investigations, which showed that the co-expressions of Survivin and Bcl-2 play an important role in drug induced apoptosis 22&23 . The data suggest that aculeatiside-A may serve as a potential therapeutic agent for hepatocellular carcinoma. The in-vivo anti-tumor effects of aculeatiside-A as well as its potential clinical effectiveness need further and profound investigation (as shown in figure 6 ).
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